Tag Stem cells
Scientists make multiple types of white blood cells directly from embryonic and adult stem cells
In an advance that could help transform embryonic stem cells into a multipurpose medical tool, scientists at the University of Wisconsin–Madison have transformed these versatile cells into progenitors of white blood cells and into six types of mature white blood and immune cells. Read More
First cGMP feeder-independent pluripotent stem cell banks released for distribution
The WiCell Research Institute and the Waisman Clinical Biomanufacturing Facility (WCBF) announced today (July 6) the release of the first current Good Manufacturing Practices (cGMP) feeder-independent pluripotent stem cell banks available for sale and distribution to researchers worldwide. Read More
WARF signs license agreement with Pfizer for human embryonic stem cells
Pfizer Inc., a major biopharmaceutical company, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin–Madison, announced May 5 that they have signed a license for human embryonic stem (hES) cell patents for the development of new drug therapies. Read More
Wisconsin, Morgridge scientists excise vector, exotic genes from induced stem cells
A team of scientists from the Morgridge Institute for Research at the University of Wisconsin–Madison reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes. Read More
Professor comments on Obama’s stem cell executive action
Following is a statement from James Thomson, University of Wisconsin–Madison professor of anatomy, on President Barack Obama's decision to lift restrictions on federal funding for human embryonic stem cell research. Read More
How do you mend a broken heart? Maybe someday with stem cells made from your skin
A little more than a year after University of Wisconsin–Madison scientists showed they could turn skin cells back into stem cells, they have pulsating proof that these "induced" stem cells can indeed form the specialized cells that make up heart muscle. Read More
Cellartis, WARF sign license agreement for human embryonic stem cells
Cellartis AB, a premier provider of human embryonic stem cell (hES) derived products and technologies, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin–Madison, announced today (Jan. 15) that they have signed a license for hES patents that enables Cellartis to commercialize undifferentiated hES cell products in the U.S. Read More
All NIH human embryonic stem cell registry lines now deposited at NSCB
The U.S. National Stem Cell Bank (NSCB) has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden. With the addition of the new lines, the National Stem Cell Bank now has received all 21 cell lines from the six providers listed on the National Institutes of Health (NIH) federal registry. Read More
Patient-derived induced stem cells retain disease traits
When neurons started dying in Clive Svendsen's lab dishes, he couldn't have been more pleased. The dying cells - the same type lost in patients with the devastating neurological disease spinal muscular atrophy - confirmed that the University of Wisconsin–Madison stem cell biologist had recreated the hallmarks of a genetic disorder in the lab, using stem cells derived from a patient. Read More
James Thomson receives 2008 Massry Prize honoring stem cell researchers
James Thomson, director of regenerative biology at the Morgridge Institute for Research and John D. MacArthur Professor at the University of Wisconsin–Madison School of Medicine and Public Health, has received the prestigious Massry Prize for 2008. The award recognizes Thomson for his groundbreaking discovery made a decade ago of human embryonic stem (ES) cells and his subsequent work in developing induced pluripotent stem (iPS) cells. Read More
VistaGen, WARF sign license agreement for human embryonic stem cell technology
VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools. Read More
A decade celebrating stem cells: Changing the face of medicine
The Wisconsin Academy, along with the University of Wisconsin–Madison and the Wisconsin Alumni Research Foundation (WARF), will host a free, two-day event on Nov. 18-19 to highlight the accomplishments of stem cell research in the state and to examine future stem cell issues. Read More
Research on human embryonic stem cells marks 10-year milestone
Ten years ago today (Nov. 6, 1998), the publication in the journal Science of a short paper entitled "Embryonic Stem Cell Lines Derived from Human Blastocysts" rocked biology - and the world - as the all-purpose stem cell and its possibilities were ushered into the limelight. Read More
Conference to celebrate a decade of stem cell research
The Wisconsin Academy, along with UW–Madison and the Wisconsin Alumni Research Foundation (WARF), will host a free, two-day event to highlight the accomplishments of stem cell research in the state and to examine future stem cell issues. Read More
Engineered stem cells carry promising ALS therapy
Using adult stem cells from bone marrow as "Trojan horses" to deliver a nurturing growth factor to atrophied muscles, Wisconsin scientists have successfully slowed the progression of ALS in rats. Read More
World Stem Cell Summit comes to Madison Sept. 21–23
An opportunity to meet stem cell experts from around the world, unique networking opportunities and a public day of outreach await those attending the World Stem Cell Summit and related events Sunday–Tuesday, Sept. 21–23. Read More
World Stem Cell Summit comes to Madison Sept. 21-23
Meeting stem cell experts from around the world, unique networking opportunities, and a public day of outreach await those attending the World Stem Cell Summit and related events Sept. 21-23 in Madison, Wis. Read More
WiCell Research Institute launches new stem cell bank
The WiCell Research Institute, a private, not-for-profit supporting organization to the University of Wisconsin–Madison, is launching its own stem cell bank to distribute cell lines beyond the 21 lines eligible for federal funding and distribution through the National Stem Cell Bank (NSCB). Read More
World Stem Cell Summit offers registration discounts to UW–Madison community
The Stem Cell and Regenerative Medicine Center and the WiCell Research Institute will help supplement World Stem Cell Summit registrations for a limited number of faculty, staff, students and trainees. Read More